• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

A Systematic Review of Unichiral Drugs: Therapeutic Applications and Pharmaceutical Considerations
  • VIEWS 5
  • PDF 3

Journal of Pharmaceutical Research

DOI: 10.18579/jopcr/v23.4.63

Year: 2024, Volume: 23, Issue: 4, Pages: 204-214

Systematic Review

A Systematic Review of Unichiral Drugs: Therapeutic Applications and Pharmaceutical Considerations

Arbind Kumar Chaudhary1,∗, A Sudhindra Prathap2, Reetesh Kumar Rai3, Feroz Khan4

1Assistant Professor of Pharmacology, Government Erode Medical College and Hospital, Tamil Nadu, India
2Tutor, Dept of Pharmacology, SDM college of medical sciences and hospital, Dharwad, Karnataka, India
3Associate Professor, Dept. of Pharmacology, MRA Medical College, Ambedkar Nagar, UP, India
4Assistant Professor of Anatomy, Government Erode Medical College and Hospital, Tamil Nadu, India

*Corresponding Author
Email: [email protected]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Background: Chirality is an essential property of several molecules and a topic on which depend most medicinal chemistry works, that influence the biological activity of drugs . Unichiral drugs, which are defined to be two enantiomers that differ only in the absolute configuration at a single chiral centre, are an important class in the pharmaceutical industry arguably offering superior therapeutic efficacy and lower side effects compared to their racemic counterparts. This systematic review will evaluate the therapeutic uses and pharmaceutical aspects of unichiral drugs by combining the existing literature record to discuss their implications for drug development and clinical use. Methods: Databases were searched using a structured approach according to PRISMA guidelines for systematic searches. This Review comprises 11 original research studies that were identified on the basis of predefined criteria pertaining to unichiral drugs. There were two phases to data extraction, consisting of qualitative and quantitative analyses and quality appraisals referring to the overall credibility of the studies. Result: Unichiral drugs were obtained to be more enantiomerically pure, bioavailable and therapeutically effective than the racemates. Unichiral presentations, especially reduced side effects and subsequently improved patient adherence. Comprehensive cross-study comparisons showed that unichiral drugs display a number of distinct therapeutic benefits, paving the way for discovery of new pharmacotherapies. This review highlights the relevance of unichiral drugs in current medicine and promotes further investigation on their innovation and regulatory pathways. Long-term clinical effects, cost-effectiveness as well as new synthesis method development in order to improve unichiral drugs production should be further studied. Conclusion: Enantiopure drugs represent an attractive frontier of drug development, offering unequivocal advantages over racemic formulations. Clinical evidence to support unichiral strategy was accumulated for improvement of efficacy and reduction of adverse effect.

Keywords: Chirality, Pharmacology, Pharmaceutical sciences, Drug­therapy interaction, Drug development, Therapeutic applications, Enantiomeric purity, Unichiral drugs, Bioavailability, Clinical efficacy

References

  1. Gal J. Francotte E, Lindner W., eds. Chiral drugs from a historical point of view, Methods and Principles in Medicinal Chemistry. (Vol. 33) Weinheim. WILEY-VCH. 2006.
  2. Hadžidedić Š, Uzunović A, Jazić SŠ, El-Arini SK. The impact of chirality on the development of robust and stable tablet formulation of (S-) amlodipine besylate. Pharmaceutical Development and Technology. 2014;19(8):930–941. Available from: https://doi.org/10.3109/10837450.2013.840847
  5. Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, et al. Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective α1B-adrenoceptor antagonist. European Journal of Medicinal Chemistry. 2012;58:184–191. Available from: https://doi.org/10.1016/j.ejmech.2012.09.049
  6. Aboul-Enein HY, Kannappan V, Kanthiah S. Impact of cyclofructan derivatives as efficient chiral selector in chiral analysis: an overview. Chirality. 2022;34(2):364–373. Available from: https://doi.org/10.1002/chir.23396
  8. Sui J, Zhang J, Ching CB, Chen WN. Expanding proteomics into the analysis of chiral drugs. Molecular BioSystems. 2009;5(6):603–608. Available from: https://doi.org/10.1039/B903858B
  9. Bhandari P, Shah C, Surwade S. Chirality-Today and Tomorrow's Way of Treatment. In: API Textbook of Medicine. (pp. 178-181) API India. 2008.
  12. Andreu I, Sinicropi MS, Catalano A, et al. A Look at the Importance of Chirality in Drug Activity: Some Significative Examples. Applied Sciences. 2022;12(21):1–22. Available from: https://doi.org/10.3390/app122110909
  13. Hogg D. Chiral Switch Strategies in Drug Development: Implications and Opportunities. Future Medicinal Chemistry. 2021;13(4):307–318. Available from: https://doi.org/10.4155/fmc-2020-0200
  14. Peters JR, Dervan PB. The Role of Chirality in Medicinal Chemistry. Chemistry & Biology. 2020;27(7):852–862. Available from: https://doi.org/10.1016/j.chembiol.2020.05.006
  15. Torssell KB. Stereochemistry in Drug Development: The Case for Enantiomeric Purity. Journal of Medicinal Chemistry. 2020;63(1):14–28. Available from: https://doi.org/10.1021/acs.jmedchem.9b00832
  16. Williams HR, Kwan SH. The Challenges of Chirality in Drug Discovery: Strategies and Solutions. Drug Discovery Today. 2019;24(7):1441–1450. Available from: https://doi.org/10.1016/j.drudis.2019.03.015
  17. Zhao M, Zhang A. Exploring the Importance of Chirality in Drug Design and Development. European Journal of Medicinal Chemistry. 2021;217. Available from: https://doi.org/10.1016/j.ejmech.2021.113363

Copyright

© 2024 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/) 

  • 20 January 2025

Year: 2024, Volume: 23, Issue: 4


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.